Ang II Enhances Noradrenaline Release from Sympathetic Nerve Endings Thus Contributing to the Up-Regulation of Metalloprotease-2 in Aortic Dissection Patients' Aorta Wall

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Hu, Zhipeng ^a,b   Wang, Zhiwei ^a   Wu, Hongbing ^a   Yang, Zhimin ^b   Jiang, Wanli ^a   Li, Luocheng ^a   Hu, Xiaoping ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Xiangyang Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DOXAZOSIN; GELATINASE A; GELATINASE B; GUANETHIDINE; LOSARTAN; MATRIX METALLOPROTEINASE 15; METOPROLOL; NORADRENALIN;

ADULT; ANIMAL TISSUE; AORTA DISSECTION; AORTA WALL; ARTICLE; CHEMICAL SYMPATHECTOMY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOLECULAR MECHANICS; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SYMPATHETIC NERVE; TISSUE LEVEL; UPREGULATION; ADRENERGIC NERVE; ANIMAL; AORTA; DISSECTING ANEURYSM; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC FIBERS; ANEURYSM, DISSECTING; ANGIOTENSIN II; ANIMALS; AORTA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOTOPE LABELING; LOSARTAN; MATRIX METALLOPROTEINASE 2; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84886080695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076922     Document Type: Article

References (41)

1. Kurihara T, Shimizu-Hirota R, Shimoda M, Adachi T, Shimizu H, et al. (2012) Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation 126: 3070-3080.
2. Tieu BC, Lee C, Sun H, Lejeune W, Recinos AR, et al. (2009) An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 119: 3637-3651.
3. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, et al. (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117-121.
4. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, et al. (2008) Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358: 2787-2795.
5. Forteza A, Evangelista A, Sanchez V, Teixido G, Garcia D, et al. (2011) Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome. Rev Esp Cardiol 64: 492-498.
6. Gersony DR, McClaughlin MA, Jin Z, Gersony WM, (2007) The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis. Int J Cardiol 114: 303-308.
7. von Kodolitsch Y, Csosz SK, Koschyk DH, Schalwat I, Loose R, et al. (2003) Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation 107: 1158-1163.
8. Shores J, Berger KR, Murphy EA, Pyeritz RE, (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 330: 1335-1341.
9. Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, et al. (2009) ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 296: H1660-H1665.
10. Faugeroux J, Nematalla H, Li W, Clement M, Robidel E, et al. (2013) Angiotensin II Promotes Thoracic Aortic Dissections and Ruptures in Col3a1 Haploinsufficient Mice. Hypertension.
11. Dab H, Hachani R, Hodroj W, Sakly M, Bricca G, et al. (2009) Differential control of MMP and t-PA/PAI-1 expressions by sympathetic and renin-angiotensin systems in rat left ventricle. Auton Neurosci 150: 27-32.
12. Bealer SL, (2000) Systemic angiotensin II and volume expansion release norepinephrine in the preoptic recess. Brain Res 864: 291-297.
13. Ellis JL, Burnstock G, (1989) Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens. Br J Pharmacol 97: 1157-1164.
14. Fabiani ME, Sourial M, Thomas WG, Johnston CI, Johnston CI, et al. (2001) Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. J Endocrinol 171: 97-108.
15. Liu FY, Cogan MG, (1988) Angiotensin II stimulation of hydrogen ion secretion in the rat early proximal tubule. Modes of action, mechanism, and kinetics. J Clin Invest 82: 601-607.
16. Salman IM, Sattar MA, Ameer OZ, Abdullah NA, Yam MF, et al. (2010) Role of norepinephrine & angiotensin II in the neural control of renal sodium & water handling in spontaneously hypertensive rats. Indian J Med Res 131: 786-792.
17. Tavares P, Fontes RC, Teixeira F, (2003) Cyclosporin effect on noradrenaline release from the sympathetic nervous endings of rat aorta. Pharmacol Res 47: 27-33.
18. Head GA, Burke SL, (2004) Sympathetic responses to stress and rilmenidine in 2K1C rabbits: evidence of enhanced nonvascular effector mechanism. Hypertension 43: 636-642.
19. Moller MN, Werther K, Nalla A, Stangerup SE, Thomsen J, et al. (2010) Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1. Laryngoscope 120: 657-662.
20. Gironacci MM, Yujnovsky I, Gorzalczany S, Taira C, Pena C, (2004) Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats. Regul Pept 118: 45-49.
21. DiBona GF, (2000) Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36: 1083-1088.
22. Rathore HA, Munavvar AS, Abdullah NA, Khan AH, Fathihah B, et al. (2009) Interaction between renin-angiotensin and sympathetic nervous systems in a rat model of pressure overload cardiac hypertrophy. Auton Autacoid Pharmacol 29: 171-180.
23. Teisman AC, Westerink BH, van Veldhuisen DJ, Scholtens E, de Zeeuw D, et al. (2000) Direct interaction between the sympathetic and renin-angiotensin system in myocardial tissue: a microdialysis study in anaesthetised rats. J Auton Nerv Syst 78: 117-121.
24. Falkay G, Spiegl G, Csonka D, Zupko I, (2007) Effects of streptozotocin-induced diabetes on the uterine adrenergic nerve function in pregnant rats. A superfusion study. Neurochem Int 51: 306-310.
25. Scholze P, Orr-Urtreger A, Changeux JP, McIntosh JM, Huck S, (2007) Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation. Br J Pharmacol 151: 414-422.
26. Schulte K, Kumar M, Zajac JM, Schlicker E, (2011) Noradrenaline release in rodent tissues is inhibited by interleukin-1beta but is not affected by urotensin II, MCH, NPW and NPFF. Pharmacol Rep 63: 102-111.
27. Cabassi A, Coghi P, Govoni P, Barouhiel E, Speroni E, et al. (2005) Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab 90: 2888-2897.
28. Uresin Y, Erbas B, Ozek M, Ozkok E, Gurol AO, (2004) Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress. J Renin Angiotensin Aldosterone Syst 5: 93-96.
29. Heath JW, Burnstock G, (1977) Selectivity of neuronal degeneration produced by chronic guanethidine treatment. J Neurocytol 6: 397-405.
30. Ikonomidis JS, Jones JA, Barbour JR, Stroud RE, Clark LL, et al. (2006) Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation 114: I365-I370.
31. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA, (2004) Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 78: 2106-2111, 2106-2110, 2110-2111.
32. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HJ, et al. (1998) Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation 98: I331-I338, I331-I337, I337-I338.
33. Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A, (2012) Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms. Clin Sci (Lond) 123: 531-543.
34. Trivedi DB, Loftin CD, Clark J, Myers P, DeGraff LM, et al. (2013) beta-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice. Circ Res 112: 1219-1229.
35. Shen YH, Zhang L, Ren P, Nguyen MT, Zou S, et al. (2013) AKT2 confers protection against aortic aneurysms and dissections. Circ Res 112: 618-632.
36. Dab H, Hachani R, Dhaouadi N, Hodroj W, Sakly M, et al. (2012) Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II. J Renin Angiotensin Aldosterone Syst 13: 36-45.
37. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, et al. (2006) Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66: 10357-10364.
38. Tulppo MP, Huikuri HV, Tutungi E, Kimmerly DS, Gelb AW, et al. (2005) Feedback effects of circulating norepinephrine on sympathetic outflow in healthy subjects. Am J Physiol Heart Circ Physiol 288: H710-H715.
39. Dab H, Hachani R, Hodroj W, Sakly M, Bricca G, et al. (2011) Interaction between sympathetic nervous system and renin angiotensin system on MMPs expression in juvenile rat aorta. Gen Physiol Biophys 30: 271-277.
40. Rodrigues DR, Rodrigues-Diez R, Lavoz C, Rayego-Mateos S, Civantos E, et al. (2010) Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-beta-independent process. PLoS One 5: e14145.
41. Yokoyama U, Ishiwata R, Jin MH, Kato Y, Suzuki O, et al. (2012) Inhibition of EP4 signaling attenuates aortic aneurysm formation. PLoS One 7: e36724.